Life Sciences

Marlborough medical device manufacturer CardioFocus, Inc. has begun clinical trials of a new system to treat atrial fibrillation.

Medical technology firm Hologic is teaming up with the University of Minnesota to help coaches and professional trainers tailor athletes' bodies to their specific sport or position.

Framingham international healthcare and life science firm Alira Health has acquired a contract research company just down the street.

A pharmaceutical and biotech campus development firm is set to purchase the former MetroWest Daily News building in Framingham.

Biostage, a Holliston-based biotech specializing in regenerative medicine to treat diseases of the throat, announced on Tuesday its first esophageal implant resulted in a regenerated esophageal tube.

Holliston biotech Biostage has appointed another medical professional to its scientific advisory board as the company continues its makeover following a near bankruptcy position just months ago.

The California bioscience company once considered to be the anchor of a Worcester biomanufacturing campus is planning to open a new facility in a 69,000-square-foot Hopkinton building.

Holliston biotech Biostage has secured another investment, $1 million from a private investor named Jinhui Liu.

Holliston biotech has appointed a Connecticut children's hospital doctor to its scientific advisory board less than a month after the company closed on a $100,000 investment from the same hospital.

Marlborough medical device maker Boston Scientific announced Wednesday an agreement with Santa Rosa-based Millipede, Inc. to potentially acquire the California firm for $540 million.